Literature DB >> 30745265

Role of IgG3 in Infectious Diseases.

Timon Damelang1, Stephen J Rogerson2, Stephen J Kent1, Amy W Chung3.   

Abstract

IgG3 comprises only a minor fraction of IgG and has remained relatively understudied until recent years. Key physiochemical characteristics of IgG3 include an elongated hinge region, greater molecular flexibility, extensive polymorphisms, and additional glycosylation sites not present on other IgG subclasses. These characteristics make IgG3 a uniquely potent immunoglobulin, with the potential for triggering effector functions including complement activation, antibody (Ab)-mediated phagocytosis, or Ab-mediated cellular cytotoxicity (ADCC). Recent studies underscore the importance of IgG3 effector functions against a range of pathogens and have provided approaches to overcome IgG3-associated limitations, such as allotype-dependent short Ab half-life, and excessive proinflammatory activation. Understanding the molecular and functional properties of IgG3 may facilitate the development of improved Ab-based immunotherapies and vaccines against infectious diseases.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  IgG3; allotypes; antibody; antibody-dependent cell cytotoxicity; complement; glycosylation

Mesh:

Substances:

Year:  2019        PMID: 30745265     DOI: 10.1016/j.it.2019.01.005

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  45 in total

1.  Protein-based, but not viral vector alone, HIV vaccine boosting drives an IgG1-biased polyfunctional humoral immune response.

Authors:  Stephanie Fischinger; Sally Shin; Carolyn M Boudreau; Margaret Ackerman; Supachai Rerks-Ngarm; Punnee Pitisuttithum; Sorachai Nitayaphan; Jerome H Kim; Merlin L Robb; Nelson L Michael; Robert J O'Connell; Sandhya Vasan; Hendrik Streeck; Galit Alter
Journal:  JCI Insight       Date:  2020-06-18

2.  A recombinant herpes virus expressing influenza hemagglutinin confers protection and induces antibody-dependent cellular cytotoxicity.

Authors:  Katherine Kaugars; Joseph Dardick; Anna Paula de Oliveira; Kayla A Weiss; Regy Lukose; John Kim; Lawrence Leung; Saranathan Rajagopalan; Sydney Wolin; Leor Akabas; David M Knipe; Goran Bajic; William R Jacobs
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-24       Impact factor: 12.779

3.  A New Live Auxotrophic Vaccine Induces Cross-Protection against Klebsiella pneumoniae Infections in Mice.

Authors:  Miriam Moscoso; Juan A Vallejo; Maria P Cabral; Patricia García; Víctor Fuentes-Valverde; Eva Gato; Jorge Arca-Suárez; Pablo Aja-Macaya; Germán Bou
Journal:  Vaccines (Basel)       Date:  2022-06-16

4.  Exploring complement-dependent cytotoxicity by rituximab isotypes in 2D and 3D-cultured B-cell lymphoma.

Authors:  Sandra Lara; Juliane Heilig; Alexander Virtanen; Sandra Kleinau
Journal:  BMC Cancer       Date:  2022-06-20       Impact factor: 4.638

5.  Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccine.

Authors:  Leonie M Weskamm; Anahita Fathi; Matthijs P Raadsen; Anna Z Mykytyn; Till Koch; Michael Spohn; Monika Friedrich; Bart L Haagmans; Stephan Becker; Gerd Sutter; Christine Dahlke; Marylyn M Addo
Journal:  Cell Rep Med       Date:  2022-07-19

6.  Cryomicroscopy reveals the structural basis for a flexible hinge motion in the immunoglobulin M pentamer.

Authors:  Qu Chen; Rajesh Menon; Lesley J Calder; Pavel Tolar; Peter B Rosenthal
Journal:  Nat Commun       Date:  2022-10-23       Impact factor: 17.694

7.  Recent insights into Fc-mediated effector responses to HIV-1.

Authors:  Margaret C Carpenter; Margaret E Ackerman
Journal:  Curr Opin HIV AIDS       Date:  2020-09       Impact factor: 4.283

8.  A glycoside analog of mammalian oligomannose formulated with a TLR4-stimulating adjuvant elicits HIV-1 cross-reactive antibodies.

Authors:  Jean-François Bruxelle; Tess Kirilenko; Nino Trattnig; Yiqiu Yang; Matteo Cattin; Paul Kosma; Ralph Pantophlet
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

9.  FcγR Binding and ADCC Activity of Human IgG Allotypes.

Authors:  Steven W de Taeye; Arthur E H Bentlage; Mirjam M Mebius; Joyce I Meesters; Suzanne Lissenberg-Thunnissen; David Falck; Thomas Sénard; Nima Salehi; Manfred Wuhrer; Janine Schuurman; Aran F Labrijn; Theo Rispens; Gestur Vidarsson
Journal:  Front Immunol       Date:  2020-05-06       Impact factor: 7.561

10.  Functional Homology for Antibody-Dependent Phagocytosis Across Humans and Rhesus Macaques.

Authors:  Justin Pollara; Matthew Zirui Tay; R Whitney Edwards; Derrick Goodman; Andrew R Crowley; Robert J Edwards; David Easterhoff; Haleigh E Conley; Taylor Hoxie; Thaddeus Gurley; Caroline Jones; Emily Machiele; Marina Tuyishime; Elizabeth Donahue; Shalini Jha; Rachel L Spreng; Thomas J Hope; Kevin Wiehe; Max M He; M Anthony Moody; Kevin O Saunders; Margaret E Ackerman; Guido Ferrari; Georgia D Tomaras
Journal:  Front Immunol       Date:  2021-05-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.